/ Researchers / investigators / sicheri-frank

  

Dr. Frank Sicheri

Lunenfeld-Tanenbaum Research Institute
Mount Sinai Hospital
Joseph & Wolf Lebovic Health Complex
600 University
Toronto, Ontario
M5G 1X5

Tel.: 416-586-4800 ext.8471

► Send Email

► Lab Website

► Web of Science Researcher ID
F-8856-2013

► Publons ID
2638745

► Publications

  

Dr. Frank Sicheri

SENIOR INVESTIGATOR

Structural biologist Dr. Frank Sicheri is widely regarded as one of Canada's pre-eminent scientists in his field. He has made outstanding contributions to our understanding of the structure and function of signalling proteins, many of which are implicated in disease. His research is focused on cancer, but he has a number of projects involving molecules involved in viral infection, inflammation, and diabetes. His discoveries are critical to the development of new drugs that target these diseases.

In particular, Dr. Sicheri studies two families of signalling proteins called protein kinases and ubiquitin ligases. The human genome encodes approximately 500 protein kinases and over 600 ubiquitin ligases. These molecules act as switches within cells that regulate all biological processes. Malfunction of these proteins, which can happen as a result of genetic mutation or damage from a virus, gives rise to cellular dysfunctions that underlie numerous diseases. One common example is cancer, in which malfunctioning kinases and ubiquitin ligases cause cells to grow and multiply uncontrollably.

Scientists have found that the activity of protein kinases can be inhibited with specific drug-like molecules. As a result kinases have become an important focus by pharmaceutical companies in the development of new drugs. Drugs which inhibit specific kinases are already being used successfully to treat chronic myeloid leukemia (Gleevec), and some forms of lung cancer (Iressa). In contrast, the therapeutic potential of ubiquitin ligases as drug targets is largely untapped.

To date however, only a fraction of the protein kinases and ubiquitin ligases encoded in the human genome has been explored. Dr. Sicheri's research is directed at improving our understanding of how these proteins work by viewing them at atomic level resolution to unlock their potential as drug targets for disease. He has made key discoveries including most notably, uncovering the basis by which the RAF family kinases drive tumour formation and potential therapeutic strategies to reverse their adverse effects.

At a Glance

Dr. Frank Sicheri investigates the cellular basis of cancer, viral infection, inflammation and diabetes.

He studies the structure and function of two families of enzymes called protein kinases and ubiquitin ligases. The human genome encodes approximately 500 protein kinases and over 600 ubiquitin ligases, many of which are implicated in human disease.

He uses technologies called X-ray crystallography, nuclear magnetic resonance, and cryo electron microscopy to determine the structure of proteins at atomic resolution.

His research aims to facilitate the development of drugs to treat human disease.

Major Research Activities

Dr. Sicheri's lab is interested in the structure and function of protein kinase signaling molecules. His laboratory employs x-ray crystallography, nuclear magnetic resonance and cryo electron microscopy to determine the detailed structure of individual protein domains and their assembly into higher-order complexes. Structures that the Sicheri lab is working on include the protein kinases IRE1, RAF, NUAK2, MST1, and LATS1, and the ubiquitin ligases Cdc34 and Fbw7.

 

 

 

          
 LTRI
  About Us
   Senior Administration
   Research Committee
   Canada Research Continuity Emergency Fund
   Canada Research Chairs
   Technology Transfer
   Career Opportunities
  Researchers
   Investigators
    Dr. Irene L. Andrulis
    Dr. Rod Bremner
    Dr. Laurent Briollais
    Dr. Theodore J. Brown
    Dr. Shelley B. Bull
    Dr. Kieran Campbell
    Dr. Isabella Caniggia
    Dr. Robert F. Casper
    Dr. Graham L. Collingridge
    Dr. Sabine P. Cordes
    Dr. Joseph Culotti
    Dr. James Dennis
    Dr. Daniel J. Drucker
    Dr. Daniel Durocher
    Dr. Steven Gallinger
    Dr. Anne-Claude Gingras
    Dr. Pamela Goodwin
    Dr. Marc D. Grynpas
    Dr. Rayjean J. Hung
    Dr. Hartland W. Jackson
    Dr. Andrea Jurisicova
    Dr. Julia A. Knight
    Dr. Alexander G. Logan
    Dr. Stephen J. Lye
    Dr. Andras Nagy
    Dr. Michelle Nelson
    Dr. Kenichi Okamoto
    Dr. Laurence Pelletier
    Dr. Miguel Ramalho-Santos
    Dr. Frederick P. Roth
    Dr. Daniel Schramek
    Dr. Frank Sicheri
    Dr. Mark S. Silverberg
    Dr. Katherine Siminovitch
    Dr. Carolyn Steele Gray
    Dr. Ross Upshur
    Dr. Jim R. Woodgett
    Dr. Jeffrey Wrana
    Dr. Mei Zhen
    Dr. Bernard Zinman
   Clinician Scientists
    Dr. May Alarab
    Dr. Dominic Amato
    Dr. Amir Azarpazhooh
    Dr. Mrinalini Balki
    Dr. Chaim Bell
    Dr. Christine Brezden-Masley
    Dr. June C. Carroll
    Dr. Crystal Chan
    Dr. Martin C. Chang
    Dr. Kenneth Croitoru
    Dr. Ariel Dalfen
    Dr. Allan Detsky
    Dr. Brendan C. Dickson
    Dr. Rohan D. D’Souza
    Dr. Denice S. Feig
    Dr. Emer Finan
    Dr. John S. Floras
    Dr. Michael Fralick
    Dr. Shiphra R. Ginsburg
    Dr. Rebecca A. Gladdy
    Dr. Michael Goldberg
    Dr. Ellen Greenblatt
    Dr. Masoom A. Haider
    Dr. Jonathan J. Hunter
    Dr. Amna F. Husain
    Dr. Amish Jain
    Dr. Keith A. Jarvi
    Dr. Lianne P. Jeffs
    Dr. Jennie Johnstone
    Dr. Rita Kandel
    Dr. Edmond Kelly
    Dr. Erin D. Kennedy
    Dr. Edward C. Keystone
    Dr. James Khan
    Dr. John Kingdom
    Dr. Richard Kirsch
    Dr. Elena Kolomietz
    Dr. Caroline K. Kramer
    Dr. Stephen Lapinsky
    Dr. Shoo K. Lee
    Dr. Molyn Leszcz
    Dr. Susanna Mak
    Dr. Ann K. Malinowski
    Dr. Robert G. Maunder
    Dr. Taymaa May
    Dr. Allison McGeer
    Dr. Warren McIsaac
    Dr. Sangeeta Mehta
    Dr. Shikha Mittoo
    Dr. Ally Murji
    Dr. Kellie E. Murphy
    Dr. Geoffrey C. Nguyen
    Dr. Karel O'Brien
    Dr. Christian Pagnoux
    Dr. Claire Pain
    Dr. John Parker
    Dr. Bruce A. Perkins
    Dr. Allan Peterkin
    Dr. Aaron F. Pollett
    Dr. Paula Ravitz
    Dr. Albiruni A. Razak
    Dr. Ravi Retnakaran
    Dr. Robert H. Riddell
    Dr. Greg Ryan
    Dr. Joel Sadavoy
    Dr. Francisco J. Sanchez-Guerrero
    Dr. Amanda Selk
    Dr. Prakeshkumar Shah
    Dr. Vibhuti Shah
    Dr. Naveed Tahir Siddiqui
    Dr. Candice K. Silversides
    Dr. Daisy R. Singla
    Dr. Kim Tsoi
    Dr. Hillary A. Steinhart
    Dr. Carol Swallow
    Dr. Howard C. Tenenbaum
    Dr. Sharon L. Unger
    Dr. Chen Wang
    Dr. Alanna Weisman
    Dr. Virginia A. Wesson
    Dr. Lesley Wiesenfeld
    Dr. Rory Windrim
    Dr. Jay Wunder
    Dr. Alexandre Zlotta
   Staff Scientists
    Dr. Karen Colwill
    Dr. John Georgiou
    Dr. Gerald D. Gish
    Dr. Farzad Khalvati
    Dr. Colin Mckerlie
    Dr. Jinyi Zhang
   Associate Members / Scientists
    Dr. Gary D. Bader
    Dr. Bharati Bapat
    Dr. Marcus Bernardini
    Dr. Lisa D. Burry
    Dr. George S. Charames
    Dr. Mary Chiu
    Dr. Eleftherios P. Diamandis
    Dr. Sarah Ferguson
    Dr. Michael Glogauer
    Dr. Jack M. Goodman
    Dr. Tae Hart
    Dr. Johannes Keunen
    Dr. Sarina Isenberg
    Dr. Jordan Lerner-Ellis
    Dr. Zhong-Cheng Luo
    Dr. Stephen G. Matthews
    Dr. John R. McLaughlin
    Dr. Helen McNeill
    Dr. Massieh Moayedi
    Dr. Abdul Noor
    Dr. Ian M. Rogers
    Dr. Mike Tyers
    Dr. Pete Wegier
   Physician Directory
  Research Resources
   Our Research
   Expertise
  Training Centre
  News
   Spotlight
    Innovations in prostate cancer research during moustache season and beyond
    New genetic discoveries offer hope to IBD patients
    Diabetes: disease of the 21st century will affect approximately 500 million by 2030
    What does a worm’s nervous system tell us about disorders like Huntington’s Disease?
    The Year in Review: 2012 Highlights from the Samuel Lunenfeld Research Institute
    Millennials Help Scientists Transform Breast Cancer Research
    How Research Impacts Your Health
    2013 International Symposium: Frontiers in Diabetes Research
    $35 Million Gift from Larry and Judy Tanenbaum Launches Fundraising Drive for Endowment to Support Medical Research
    Director warns why we shouldn't neglect basic science in favour of applied science
    The anatomy of a major discovery
    Unravelling the mysteries of complex brain disorders
    LTRI Q&A: How do we predict breast cancer risk more effectively?
    Michal Zimmermann and his efforts to improve cancer drug efficacy
    Dheva Setiaputra
    Salomé Adam
   Discovery Corner
    Not your typical March Break: the life of an intern at the LTRI
  COVID-19
  Aside
   Slides relating to the recommendations of CANADA'S FUNDAMENTAL SCIENCE REVIEW